Yüklüyor......

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia: A case report

BACKGROUND: Hereditary hemorrhagic telangiectasia is an inherited autosomal dominant disease presenting with recurrent bleeding episodes and iron deficiency anemia due to vascular malformations. Hereditary hemorrhagic telangiectasia is associated with an increased risk of stroke, gastrointestinal bl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Wien Klin Wochenschr
Asıl Yazarlar: Huemer, Florian, Dejaco, Martin, Grabmer, Christoph, Melchardt, Thomas, Neureiter, Daniel, Mayer, Georg, Egle, Alexander, Greil, Richard, Weiss, Lukas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Vienna 2016
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318479/
https://ncbi.nlm.nih.gov/pubmed/27878613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-016-1124-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!